• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙减重手术的使用和医院结局变化(2016-2022):使用倾向评分匹配分析 2 型糖尿病的作用。

Changes in use and hospital outcomes of bariatric surgery in Spain (2016-2022): analysis of the role of type 2 diabetes using propensity score matching.

机构信息

Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Department of Public Health & Maternal and Child Health, Universidad Complutense de Madrid, Madrid, Spain

出版信息

BMJ Open Diabetes Res Care. 2024 Aug 3;12(4):e004351. doi: 10.1136/bmjdrc-2024-004351.

DOI:10.1136/bmjdrc-2024-004351
PMID:39097299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11298724/
Abstract

INTRODUCTION

The objectives of this study were to examine temporal trends in the incidence of bariatric surgery (Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG)) in patients with and without type 2 diabetes mellitus (T2DM). Outcomes of hospitalization and the impact of T2DM on these outcomes were also analyzed.

RESEARCH DESIGN AND METHODS

We performed an observational study with the Spanish national hospital discharge database. Obese patients with and without T2DM who underwent RYGB and SG between 2016 and 2022 were identified. Propensity score matching (PSM) and logistic regression were used to compare patients with and without T2DM and to evaluate the effect of T2DM and other variables on outcomes of surgery. A variable "severity" was created to cover patients who died in hospital or were admitted to the intensive care unit (ICU).

RESULTS

A total of 32,176 bariatric surgery interventions were performed (28.86% with T2DM). 31.57% of RYGBs and 25.53% of SG patients had T2DM. The incidence of RYGB and SG increased significantly between 2016 and 2022 (p<0.001), with a higher incidence in those with T2DM than in those without (incidence rate ratio 4.07 (95% CI 3.95 to 4.20) for RYGB and 3.02 (95% CI 2.92 to 3.14) for SG). In patients who underwent SG, admission to the ICU and severity were significantly more frequent in patients with T2DM than in those without (both p<0.001). In the multivariate analysis, having T2DM was associated with more frequent severity in those who received SG (OR 1.23; 95% CI 1.07 to 1.42).

CONCLUSIONS

Between 2016 and 2022, bariatric surgery procedures performed in Spain increased in patients with and without T2DM. More interventions were performed on patients with T2DM than on patients without T2DM. RYGB was the most common procedure in patients with T2DM. The presence of T2DM was associated with more severity after SG.

摘要

简介

本研究旨在探讨伴有和不伴有 2 型糖尿病(T2DM)的患者行减重手术(胃旁路术[RYGB]和袖状胃切除术[SG])的发病率随时间的变化趋势。还分析了住院治疗结果以及 T2DM 对这些结果的影响。

研究设计和方法

我们进行了一项观察性研究,使用了西班牙国家住院数据库。确定了 2016 年至 2022 年间患有 T2DM 和不患有 T2DM 而接受 RYGB 和 SG 的肥胖患者。采用倾向评分匹配(PSM)和逻辑回归比较患有和不患有 T2DM 的患者,并评估 T2DM 和其他变量对手术结果的影响。创建了一个“严重程度”变量,以涵盖在医院死亡或入住重症监护病房(ICU)的患者。

结果

共进行了 32176 例减重手术干预(28.86%患有 T2DM)。RYGB 患者中 31.57%和 SG 患者中 25.53%患有 T2DM。2016 年至 2022 年间,RYGB 和 SG 的发病率显著增加(p<0.001),患有 T2DM 的患者发病率高于不患有 T2DM 的患者(发病率比 4.07(95%CI 3.95 至 4.20),SG 为 3.02(95%CI 2.92 至 3.14))。在接受 SG 的患者中,患有 T2DM 的患者 ICU 入院和严重程度显著高于不患有 T2DM 的患者(均 p<0.001)。多变量分析显示,接受 SG 的患者中 T2DM 与更频繁的严重程度相关(OR 1.23;95%CI 1.07 至 1.42)。

结论

2016 年至 2022 年间,在西班牙进行的减重手术在患有和不患有 T2DM 的患者中均有所增加。在患有 T2DM 的患者中进行的手术多于不患有 T2DM 的患者。RYGB 是 T2DM 患者最常见的手术。SG 后,T2DM 的存在与更严重的病情相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c853/11298724/b7ec58b3a433/bmjdrc-12-4-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c853/11298724/b7ec58b3a433/bmjdrc-12-4-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c853/11298724/b7ec58b3a433/bmjdrc-12-4-g001.jpg

相似文献

1
Changes in use and hospital outcomes of bariatric surgery in Spain (2016-2022): analysis of the role of type 2 diabetes using propensity score matching.西班牙减重手术的使用和医院结局变化(2016-2022):使用倾向评分匹配分析 2 型糖尿病的作用。
BMJ Open Diabetes Res Care. 2024 Aug 3;12(4):e004351. doi: 10.1136/bmjdrc-2024-004351.
2
Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.胃旁路术与袖状胃切除术治疗糖尿病的 5 年结局比较:全国以患者为中心的临床研究网络(PCORNet)减重研究。
JAMA Surg. 2020 May 1;155(5):e200087. doi: 10.1001/jamasurg.2020.0087. Epub 2020 May 20.
3
Remission of Type 2 Diabetes Mellitus (T2DM) after Sleeve Gastrectomy (SG), One-Anastomosis Gastric Bypass (OAGB), and Roux-en-Y Gastric Bypass (RYGB): A Systematic Review.袖状胃切除术(SG)、单吻合口胃旁路术(OAGB)和 Roux-en-Y 胃旁路术(RYGB)治疗 2 型糖尿病(T2DM)缓解的系统评价。
Medicina (Kaunas). 2023 May 19;59(5):985. doi: 10.3390/medicina59050985.
4
National Trends in Bariatric Surgery 2012-2015: Demographics, Procedure Selection, Readmissions, and Cost.2012 - 2015年减肥手术的全国趋势:人口统计学、手术选择、再入院情况及费用
Obes Surg. 2017 Nov;27(11):2933-2939. doi: 10.1007/s11695-017-2719-1.
5
Metabolic effects of bariatric surgery on patients with type 2 diabetes: a population-based study.减重手术对 2 型糖尿病患者代谢的影响:基于人群的研究。
Surg Obes Relat Dis. 2021 Jul;17(7):1349-1358. doi: 10.1016/j.soard.2021.02.014. Epub 2021 Feb 18.
6
Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.胃旁路术(RYGB)、袖状胃切除术(SG)和单吻合口胃旁路术(OAGB)治疗 2 型糖尿病缓解:减肥手术研究的纵向评估结果。
BMC Endocr Disord. 2022 Oct 26;22(1):260. doi: 10.1186/s12902-022-01171-8.
7
Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database.基于代谢与减重外科认证和质量改进计划数据库的袖状胃切除术与 Roux-en-Y 胃旁路术 30 天结果:首次报告。
Surg Obes Relat Dis. 2018 May;14(5):545-551. doi: 10.1016/j.soard.2018.01.011. Epub 2018 Jan 13.
8
[Analysis of early severe postoperative complications and risk factors in 4255 patients who underwent bariatric and metabolic surgery in a single cente].[单中心4255例肥胖与代谢手术患者术后早期严重并发症及危险因素分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Oct 25;25(10):899-905. doi: 10.3760/cma.j.cn441530-20220712-00300.
9
Concurrent minimally invasive bariatric surgery and ventral hernia repair with mesh; Is it safe? Propensity score matching analysis using the 2015-2022 MBSAQIP database.同期进行的微创减重手术与使用补片的腹疝修补术;安全吗?利用2015 - 2022年MBSAQIP数据库进行倾向评分匹配分析。
Surg Endosc. 2024 Dec;38(12):7544-7551. doi: 10.1007/s00464-024-11260-5. Epub 2024 Sep 17.
10
30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data.袖状胃切除术、Roux-en-Y 胃旁路术和单吻合口胃旁路术 30 天发病率和死亡率:GENEVA 数据的倾向评分匹配分析。
Int J Obes (Lond). 2022 Apr;46(4):750-757. doi: 10.1038/s41366-021-01048-1. Epub 2021 Dec 15.

本文引用的文献

1
Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future.代谢疾病的减重与内镜治疗:过去、现在与未来。
Diabetes Res Clin Pract. 2024 May;211:111651. doi: 10.1016/j.diabres.2024.111651. Epub 2024 Apr 3.
2
Early postoperative COVID infection is associated with significantly increased risk of venous thromboembolism after metabolic and bariatric surgery.术后早期 COVID 感染与代谢和减重手术后静脉血栓栓塞的风险显著增加相关。
Surg Obes Relat Dis. 2024 Aug;20(8):730-736. doi: 10.1016/j.soard.2024.01.021. Epub 2024 Feb 8.
3
Outcomes of primary versus conversional Roux-En-Y gastric bypass after laparoscopic sleeve gastrectomy: a retrospective propensity score-matched cohort study.
腹腔镜袖状胃切除术后行原发性与转换性 Roux-En-Y 胃旁路术的结果比较:一项回顾性倾向评分匹配队列研究。
BMC Surg. 2024 Mar 6;24(1):84. doi: 10.1186/s12893-024-02374-7.
4
IFSO Worldwide Survey 2020-2021: Current Trends for Bariatric and Metabolic Procedures.2020-2021 年 IFSO 全球调查:减重与代谢手术的当前趋势。
Obes Surg. 2024 Apr;34(4):1075-1085. doi: 10.1007/s11695-024-07118-3. Epub 2024 Mar 4.
5
Comparing Safety and Efficacy Outcomes of Gastric Bypass and Sleeve Gastrectomy in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.胃旁路手术与袖状胃切除术治疗2型糖尿病患者的安全性和疗效结果比较:一项系统评价和荟萃分析
Cureus. 2024 Jan 23;16(1):e52796. doi: 10.7759/cureus.52796. eCollection 2024 Jan.
6
Patient Outcomes and Rate of Intensive Care Unit Admissions Following Bariatric Surgery: A Retrospective Cohort Study of 775 Patients.减肥手术后的患者预后及重症监护病房收治率:一项对775例患者的回顾性队列研究
Cureus. 2023 Nov 29;15(11):e49667. doi: 10.7759/cureus.49667. eCollection 2023 Nov.
7
Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish Obese Subjects.基线时患有或不患有 2 型糖尿病的瑞典肥胖受试者接受减重手术或常规治疗后的预期寿命。
Int J Obes (Lond). 2023 Oct;47(10):931-938. doi: 10.1038/s41366-023-01332-2. Epub 2023 Jul 12.
8
National usage of bariatric surgery for class I obesity: an analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program.I 类肥胖症的全国减肥手术使用情况:代谢与减肥手术认证及质量改进计划分析
Surg Obes Relat Dis. 2023 Nov;19(11):1255-1262. doi: 10.1016/j.soard.2023.05.014. Epub 2023 May 22.
9
Remission of Type 2 Diabetes Mellitus (T2DM) after Sleeve Gastrectomy (SG), One-Anastomosis Gastric Bypass (OAGB), and Roux-en-Y Gastric Bypass (RYGB): A Systematic Review.袖状胃切除术(SG)、单吻合口胃旁路术(OAGB)和 Roux-en-Y 胃旁路术(RYGB)治疗 2 型糖尿病(T2DM)缓解的系统评价。
Medicina (Kaunas). 2023 May 19;59(5):985. doi: 10.3390/medicina59050985.
10
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments.肥胖与 2 型糖尿病:流行病学、发病机制和治疗中的关联。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1161521. doi: 10.3389/fendo.2023.1161521. eCollection 2023.